FindTrial
Sign In

Effect of Shankha Bhasma on Amlapitta wsr to Dyspepsia

Comparative Pharmaceutico Analytical Standardization of Shankha Bhasma and its Clinical evaluation on Amlapitta wsr to Dyspepsia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031041
Enrollment
20
Registered
2021-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: Shankha bhasma I with amalaki churna: 125 mg BD shankha bhasma along with 3 gm amalaki churna for 30 days Control Intervention1: Shankha bhasma II with amalaki churna: 125 mg BD shankh

Sponsors

Principal RGGPG ayurvedic College paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) patients willing for trial. b) patients in age group between 18-60 years. c) patients of either sex suffering from the symptoms. d) patients suffering from the symptoms of amlapitta.

Exclusion criteria

Exclusion criteria: a) Patients not willing for the trial. b) patients 60 years of age. c) History of gastric ulcer/surgery. d) Those using aspirin or other NSAIDs. e) Malignancy,Cardiac problems, Tuberculosis,CRF. f) alarming symptoms like weight loss,GI bleeding and any other serious ailments.

Design outcomes

Primary

MeasureTime frame
Fulfillment of subjective and objective criteria.Timepoint: 30 days—

Secondary

MeasureTime frame
General feeling of well being.Timepoint: 30 days—

Countries

India

Contacts

Public ContactDr Arpita Sharma

RGGPG ayurvedic College paprola

Chanderpaul.kashyap@gmail.com7018010803

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026